Notes to editors:
About the Gyrolab system for protein quantification
Gyrolab is a fully automated system for protein quantification.
It features a microlaboratory in a compact disc (CD) format where
immunoassays are performed at nanoliter scale.
The system consists of Gyrolab Workstation LIF and Gyrolab Bioaffy®
CD microlaboratory (facilitating miniaturized and integrated applications).
The CD microlaboratories are processed by the Gyrolab Workstation,
providing a simple to use, precisely controlled system for processing
hundreds of samples in parallel. Scientists are able to use immunoassays
with a very broad measurement range to generate more information
from less sample, improving both productivity and effectiveness.
More information about the Gyrolab system can be found at www.gyros.com
About Gyros AB
Gyros is the leader in the miniaturization and integration of laboratory
applications through its proprietary micro-fluidics platform, Gyrolab
CD micro-laboratory.
Gyros delivers simple-to-use, precisely-controlled solutions for
processing hundreds of samples in parallel, generating more information
from less sample and improving lab productivity and efficiency.
Application-specific microlaboratories use a modular design offering
the potential to run different applications on a single instrument
and to create customized solutions. The company’s main focus
is on providing high-performance, quantitative, screening tools
for the development of therapeutic proteins.
Gyros has over 60 employees working at its headquarters and European
sales office in Uppsala, Sweden and its sales offices in the USA.
MedImmune, a part of AstraZeneca, is involved in research
and development of new pharmaceuticals. The head-office of MedImmune
is in Maryland, USA.
www.medimmune.com
ProBioGen is a specialist in mammalian and non-mammalian
cell engineering and production. By combining deep molecular understanding
of cells with state-of-the-art industry process engineering and
production know-how, ProBioGen’s technologies enable biopharmaceutical
companies to develop products with superior efficiency, safety and
a more favorable cost profile. ProBioGen is based in Berlin, Germany.
www.probiogen.de
Rentschler Biotechnologie in Germany is a contract manufacturing
specialist for medical research and development as well as production.
Rentschler Biotechnologie is based in Laupheim, not far from Stuttgart.
www.rentschler.de
------------------------------------------------------------------------------------------------
Statements in this press release that are not strictly historical
may be forward-looking and include risks and uncertainties. Therefore,
though based on Gyros’ current expectations, it should be
duly noted that a variety of factors could cause actual results
and experiences to differ materially from what is herein expressed.
Risks and uncertainties include, but are not limited to, risks associated
with the management of growth and international operations (including
effects of currency fluctuations), variability of operating results,
unforeseen changes in the diagnostic and pharmaceutical markets,
market competition, rapid or unexpected changes in technologies,
fluctuations in product demand, difficulties to successfully develop,
adapt, produce or commercialize products, the ability to identify
and develop new products and to differentiate products from those
of competitors, as well as various legal hazards.
------------------------------------------------------------------------------------------------
|
